APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GLP-1 Injection Market Outlook and Growth Opportunities 2026

26 December 2025209 pages

Choose your research edition.

Industry ResearchGLP-1 Injection Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Injection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal GLP-1 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Injection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global GLP-1 Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GLP-1 Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GLP-1 Injection market include Zhengda Tianqing, Innovent Biologics, Wanbang Biopharma, Sihuan Pharmaceuticals, CSPC Pharmaceutical Group, Shanghai Benemae Biopharmaceuticals Co., Ltd., Pegbio, Eli Lilly and Huadong Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP-1 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Injection Segment by Company

Zhengda Tianqing

Innovent Biologics

Wanbang Biopharma

Sihuan Pharmaceuticals

CSPC Pharmaceutical Group

Shanghai Benemae Biopharmaceuticals Co., Ltd.

Pegbio

Eli Lilly

Huadong Medicine

Hongyun Huaning

Hengrui Medicine

Hansoh Pharmaceuticals

Gan & Lee Pharmaceuticals

Borui Pharmaceuticals

Imeik

Novo Nordisk

GLP-1 Injection Segment by Type

Benaglutide

Liraglutide

Semaglutide

Tirzepatide

Others

GLP-1 Injection Segment by Application

Diabetes

Obesity

Others

GLP-1 Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GLP-1 Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GLP-1 Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GLP-1 Injection significant trends, drivers, influence factors in global and regions.

6. To analyze GLP-1 Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GLP-1 Injection industry.

Chapter 3: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GLP-1 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GLP-1 Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Injection Industry Trends Table 2. GLP-1 Injection Industry Drivers Table 3. GLP-1 Injection Industry Opportunities and Challenges Table 4. GLP-1 Injection Industry Restraints Table 5. Global GLP-1 Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GLP-1 Injection Revenue Share by Company (2021-2026) Table 7. Global GLP-1 Injection Sales Volume by Company (Units) & (2021-2026) Table 8. Global GLP-1 Injection Sales Volume Share by Company (2021-2026) Table 9. Global GLP-1 Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GLP-1 Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global GLP-1 Injection Key Company Manufacturing Base & Headquarters Table 12. Global GLP-1 Injection Company, Product Type & Application Table 13. Global GLP-1 Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Benaglutide Table 18. Significant Companies of Liraglutide Table 19. Significant Companies of Semaglutide Table 20. Significant Companies of Tirzepatide Table 21. Significant Companies of Others Table 22. Global GLP-1 Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 23. Global GLP-1 Injection Sales Volume by Type (2021-2026) & (Units) Table 24. Global GLP-1 Injection Sales Volume by Type (2027-2032) & (Units) Table 25. Global GLP-1 Injection Sales Volume Share by Type (2021-2026) Table 26. Global GLP-1 Injection Sales Volume Share by Type (2027-2032) Table 27. Global GLP-1 Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global GLP-1 Injection Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global GLP-1 Injection Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global GLP-1 Injection Sales Value Share by Type (2021-2026) Table 31. Global GLP-1 Injection Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Diabetes Table 33. Significant Companies of Obesity Table 34. Significant Companies of Others Table 35. Global GLP-1 Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global GLP-1 Injection Sales Volume by Application (2021-2026) & (Units) Table 37. Global GLP-1 Injection Sales Volume by Application (2027-2032) & (Units) Table 38. Global GLP-1 Injection Sales Volume Share by Application (2021-2026) Table 39. Global GLP-1 Injection Sales Volume Share by Application (2027-2032) Table 40. Global GLP-1 Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global GLP-1 Injection Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global GLP-1 Injection Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global GLP-1 Injection Sales Value Share by Application (2021-2026) Table 44. Global GLP-1 Injection Sales Value Share by Application (2027-2032) Table 45. Global GLP-1 Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global GLP-1 Injection Sales by Region (2021-2026) & (Units) Table 47. Global GLP-1 Injection Sales Market Share by Region (2021-2026) Table 48. Global GLP-1 Injection Sales by Region (2027-2032) & (Units) Table 49. Global GLP-1 Injection Sales Market Share by Region (2027-2032) Table 50. Global GLP-1 Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global GLP-1 Injection Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global GLP-1 Injection Sales Value Share by Region (2021-2026) Table 53. Global GLP-1 Injection Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global GLP-1 Injection Sales Value Share by Region (2027-2032) Table 55. Global GLP-1 Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global GLP-1 Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global GLP-1 Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GLP-1 Injection Sales by Country (2021-2026) & (Units) Table 60. Global GLP-1 Injection Sales Market Share by Country (2021-2026) Table 61. Global GLP-1 Injection Sales by Country (2027-2032) & (Units) Table 62. Global GLP-1 Injection Sales Market Share by Country (2027-2032) Table 63. Global GLP-1 Injection Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global GLP-1 Injection Sales Value Market Share by Country (2021-2026) Table 65. Global GLP-1 Injection Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global GLP-1 Injection Sales Value Market Share by Country (2027-2032) Table 67. Zhengda Tianqing Company Information Table 68. Zhengda Tianqing Business Overview Table 69. Zhengda Tianqing GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhengda Tianqing GLP-1 Injection Product Portfolio Table 71. Zhengda Tianqing Recent Development Table 72. Innovent Biologics Company Information Table 73. Innovent Biologics Business Overview Table 74. Innovent Biologics GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Innovent Biologics GLP-1 Injection Product Portfolio Table 76. Innovent Biologics Recent Development Table 77. Wanbang Biopharma Company Information Table 78. Wanbang Biopharma Business Overview Table 79. Wanbang Biopharma GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Wanbang Biopharma GLP-1 Injection Product Portfolio Table 81. Wanbang Biopharma Recent Development Table 82. Sihuan Pharmaceuticals Company Information Table 83. Sihuan Pharmaceuticals Business Overview Table 84. Sihuan Pharmaceuticals GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio Table 86. Sihuan Pharmaceuticals Recent Development Table 87. CSPC Pharmaceutical Group Company Information Table 88. CSPC Pharmaceutical Group Business Overview Table 89. CSPC Pharmaceutical Group GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio Table 91. CSPC Pharmaceutical Group Recent Development Table 92. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 93. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 94. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio Table 96. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 97. Pegbio Company Information Table 98. Pegbio Business Overview Table 99. Pegbio GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pegbio GLP-1 Injection Product Portfolio Table 101. Pegbio Recent Development Table 102. Eli Lilly Company Information Table 103. Eli Lilly Business Overview Table 104. Eli Lilly GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Eli Lilly GLP-1 Injection Product Portfolio Table 106. Eli Lilly Recent Development Table 107. Huadong Medicine Company Information Table 108. Huadong Medicine Business Overview Table 109. Huadong Medicine GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Huadong Medicine GLP-1 Injection Product Portfolio Table 111. Huadong Medicine Recent Development Table 112. Hongyun Huaning Company Information Table 113. Hongyun Huaning Business Overview Table 114. Hongyun Huaning GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hongyun Huaning GLP-1 Injection Product Portfolio Table 116. Hongyun Huaning Recent Development Table 117. Hengrui Medicine Company Information Table 118. Hengrui Medicine Business Overview Table 119. Hengrui Medicine GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hengrui Medicine GLP-1 Injection Product Portfolio Table 121. Hengrui Medicine Recent Development Table 122. Hansoh Pharmaceuticals Company Information Table 123. Hansoh Pharmaceuticals Business Overview Table 124. Hansoh Pharmaceuticals GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio Table 126. Hansoh Pharmaceuticals Recent Development Table 127. Gan & Lee Pharmaceuticals Company Information Table 128. Gan & Lee Pharmaceuticals Business Overview Table 129. Gan & Lee Pharmaceuticals GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio Table 131. Gan & Lee Pharmaceuticals Recent Development Table 132. Borui Pharmaceuticals Company Information Table 133. Borui Pharmaceuticals Business Overview Table 134. Borui Pharmaceuticals GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Borui Pharmaceuticals GLP-1 Injection Product Portfolio Table 136. Borui Pharmaceuticals Recent Development Table 137. Imeik Company Information Table 138. Imeik Business Overview Table 139. Imeik GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Imeik GLP-1 Injection Product Portfolio Table 141. Imeik Recent Development Table 142. Novo Nordisk Company Information Table 143. Novo Nordisk Business Overview Table 144. Novo Nordisk GLP-1 Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Novo Nordisk GLP-1 Injection Product Portfolio Table 146. Novo Nordisk Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. GLP-1 Injection Distributors List Table 150. GLP-1 Injection Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. GLP-1 Injection Product Image Figure 2. Global GLP-1 Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Injection Sales (2021-2032) & (Units) Figure 5. Global GLP-1 Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GLP-1 Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Benaglutide Image Figure 10. Liraglutide Image Figure 11. Semaglutide Image Figure 12. Tirzepatide Image Figure 13. Others Image Figure 14. Global GLP-1 Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global GLP-1 Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global GLP-1 Injection Sales Volume Share by Type (2021-2032) Figure 17. Global GLP-1 Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global GLP-1 Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global GLP-1 Injection Sales Value Share by Type (2021-2032) Figure 20. Diabetes Image Figure 21. Obesity Image Figure 22. Others Image Figure 23. Global GLP-1 Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global GLP-1 Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global GLP-1 Injection Sales Volume Share by Application (2021-2032) Figure 26. Global GLP-1 Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global GLP-1 Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global GLP-1 Injection Sales Value Share by Application (2021-2032) Figure 29. Global GLP-1 Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global GLP-1 Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global GLP-1 Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global GLP-1 Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 34. North America GLP-1 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Europe GLP-1 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific GLP-1 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 40. South America GLP-1 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa GLP-1 Injection Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa GLP-1 Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt GLP-1 Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt GLP-1 Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt GLP-1 Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. GLP-1 Injection Value Chain Figure 128. Manufacturing Cost Structure Figure 129. GLP-1 Injection Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Benaglutide
  • Liraglutide
  • Semaglutide
  • Tirzepatide
  • Others
Applications
  • Diabetes
  • Obesity
  • Others
Companies covered
  • Zhengda Tianqing
  • Innovent Biologics
  • Wanbang Biopharma
  • Sihuan Pharmaceuticals
  • CSPC Pharmaceutical Group
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • Pegbio
  • Eli Lilly
  • Huadong Medicine
  • Hongyun Huaning
  • Hengrui Medicine
  • Hansoh Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Borui Pharmaceuticals
  • Imeik
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Injection Sales Value (2021-2032)
  4. 1.2.2 Global GLP-1 Injection Sales Volume (2021-2032)
  5. 1.2.3 Global GLP-1 Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GLP-1 Injection Market Dynamics
  1. 2.1 GLP-1 Injection Industry Trends
  2. 2.2 GLP-1 Injection Industry Drivers
  3. 2.3 GLP-1 Injection Industry Opportunities and Challenges
  4. 2.4 GLP-1 Injection Industry Restraints
3 GLP-1 Injection Market by Company
  1. 3.1 Global GLP-1 Injection Company Revenue Ranking in 2025
  2. 3.2 Global GLP-1 Injection Revenue by Company (2021-2026)
  3. 3.3 Global GLP-1 Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global GLP-1 Injection Average Price by Company (2021-2026)
  5. 3.5 Global GLP-1 Injection Company Ranking (2024-2026)
  6. 3.6 Global GLP-1 Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global GLP-1 Injection Company Product Type and Application
  8. 3.8 Global GLP-1 Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GLP-1 Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GLP-1 Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GLP-1 Injection Market by Type
  1. 4.1 GLP-1 Injection Type Introduction
  2. 4.1.1 Benaglutide
  3. 4.1.2 Liraglutide
  4. 4.1.3 Semaglutide
  5. 4.1.4 Tirzepatide
  6. 4.1.5 Others
  7. 4.2 Global GLP-1 Injection Sales Volume by Type
  8. 4.2.1 Global GLP-1 Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global GLP-1 Injection Sales Volume by Type (2021-2032)
  10. 4.2.3 Global GLP-1 Injection Sales Volume Share by Type (2021-2032)
  11. 4.3 Global GLP-1 Injection Sales Value by Type
  12. 4.3.1 Global GLP-1 Injection Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global GLP-1 Injection Sales Value by Type (2021-2032)
  14. 4.3.3 Global GLP-1 Injection Sales Value Share by Type (2021-2032)
5 GLP-1 Injection Market by Application
  1. 5.1 GLP-1 Injection Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Obesity
  4. 5.1.3 Others
  5. 5.2 Global GLP-1 Injection Sales Volume by Application
  6. 5.2.1 Global GLP-1 Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GLP-1 Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global GLP-1 Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global GLP-1 Injection Sales Value by Application
  10. 5.3.1 Global GLP-1 Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GLP-1 Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global GLP-1 Injection Sales Value Share by Application (2021-2032)
6 GLP-1 Injection Regional Sales and Value Analysis
  1. 6.1 Global GLP-1 Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP-1 Injection Sales by Region (2021-2032)
  3. 6.2.1 Global GLP-1 Injection Sales by Region: 2021-2026
  4. 6.2.2 Global GLP-1 Injection Sales by Region (2027-2032)
  5. 6.3 Global GLP-1 Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GLP-1 Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global GLP-1 Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global GLP-1 Injection Sales Value by Region (2027-2032)
  9. 6.5 Global GLP-1 Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GLP-1 Injection Sales Value (2021-2032)
  12. 6.6.2 North America GLP-1 Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GLP-1 Injection Sales Value (2021-2032)
  15. 6.7.2 Europe GLP-1 Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GLP-1 Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GLP-1 Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GLP-1 Injection Sales Value (2021-2032)
  21. 6.9.2 South America GLP-1 Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GLP-1 Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GLP-1 Injection Sales Value Share by Country, 2025 VS 2032
7 GLP-1 Injection Country-level Sales and Value Analysis
  1. 7.1 Global GLP-1 Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GLP-1 Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GLP-1 Injection Sales by Country (2021-2032)
  4. 7.3.1 Global GLP-1 Injection Sales by Country (2021-2026)
  5. 7.3.2 Global GLP-1 Injection Sales by Country (2027-2032)
  6. 7.4 Global GLP-1 Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global GLP-1 Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global GLP-1 Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GLP-1 Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GLP-1 Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GLP-1 Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GLP-1 Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GLP-1 Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GLP-1 Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GLP-1 Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GLP-1 Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GLP-1 Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GLP-1 Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GLP-1 Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GLP-1 Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GLP-1 Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GLP-1 Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GLP-1 Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GLP-1 Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GLP-1 Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GLP-1 Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GLP-1 Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GLP-1 Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GLP-1 Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GLP-1 Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GLP-1 Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GLP-1 Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GLP-1 Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GLP-1 Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GLP-1 Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GLP-1 Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GLP-1 Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GLP-1 Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhengda Tianqing
  2. 8.1.1 Zhengda Tianqing Company Information
  3. 8.1.2 Zhengda Tianqing Business Overview
  4. 8.1.3 Zhengda Tianqing GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhengda Tianqing GLP-1 Injection Product Portfolio
  6. 8.1.5 Zhengda Tianqing Recent Developments
  7. 8.2 Innovent Biologics
  8. 8.2.1 Innovent Biologics Company Information
  9. 8.2.2 Innovent Biologics Business Overview
  10. 8.2.3 Innovent Biologics GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Innovent Biologics GLP-1 Injection Product Portfolio
  12. 8.2.5 Innovent Biologics Recent Developments
  13. 8.3 Wanbang Biopharma
  14. 8.3.1 Wanbang Biopharma Company Information
  15. 8.3.2 Wanbang Biopharma Business Overview
  16. 8.3.3 Wanbang Biopharma GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wanbang Biopharma GLP-1 Injection Product Portfolio
  18. 8.3.5 Wanbang Biopharma Recent Developments
  19. 8.4 Sihuan Pharmaceuticals
  20. 8.4.1 Sihuan Pharmaceuticals Company Information
  21. 8.4.2 Sihuan Pharmaceuticals Business Overview
  22. 8.4.3 Sihuan Pharmaceuticals GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sihuan Pharmaceuticals GLP-1 Injection Product Portfolio
  24. 8.4.5 Sihuan Pharmaceuticals Recent Developments
  25. 8.5 CSPC Pharmaceutical Group
  26. 8.5.1 CSPC Pharmaceutical Group Company Information
  27. 8.5.2 CSPC Pharmaceutical Group Business Overview
  28. 8.5.3 CSPC Pharmaceutical Group GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CSPC Pharmaceutical Group GLP-1 Injection Product Portfolio
  30. 8.5.5 CSPC Pharmaceutical Group Recent Developments
  31. 8.6 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  32. 8.6.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  33. 8.6.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Product Portfolio
  36. 8.6.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  37. 8.7 Pegbio
  38. 8.7.1 Pegbio Company Information
  39. 8.7.2 Pegbio Business Overview
  40. 8.7.3 Pegbio GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pegbio GLP-1 Injection Product Portfolio
  42. 8.7.5 Pegbio Recent Developments
  43. 8.8 Eli Lilly
  44. 8.8.1 Eli Lilly Company Information
  45. 8.8.2 Eli Lilly Business Overview
  46. 8.8.3 Eli Lilly GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly GLP-1 Injection Product Portfolio
  48. 8.8.5 Eli Lilly Recent Developments
  49. 8.9 Huadong Medicine
  50. 8.9.1 Huadong Medicine Company Information
  51. 8.9.2 Huadong Medicine Business Overview
  52. 8.9.3 Huadong Medicine GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huadong Medicine GLP-1 Injection Product Portfolio
  54. 8.9.5 Huadong Medicine Recent Developments
  55. 8.10 Hongyun Huaning
  56. 8.10.1 Hongyun Huaning Company Information
  57. 8.10.2 Hongyun Huaning Business Overview
  58. 8.10.3 Hongyun Huaning GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hongyun Huaning GLP-1 Injection Product Portfolio
  60. 8.10.5 Hongyun Huaning Recent Developments
  61. 8.11 Hengrui Medicine
  62. 8.11.1 Hengrui Medicine Company Information
  63. 8.11.2 Hengrui Medicine Business Overview
  64. 8.11.3 Hengrui Medicine GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hengrui Medicine GLP-1 Injection Product Portfolio
  66. 8.11.5 Hengrui Medicine Recent Developments
  67. 8.12 Hansoh Pharmaceuticals
  68. 8.12.1 Hansoh Pharmaceuticals Company Information
  69. 8.12.2 Hansoh Pharmaceuticals Business Overview
  70. 8.12.3 Hansoh Pharmaceuticals GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hansoh Pharmaceuticals GLP-1 Injection Product Portfolio
  72. 8.12.5 Hansoh Pharmaceuticals Recent Developments
  73. 8.13 Gan & Lee Pharmaceuticals
  74. 8.13.1 Gan & Lee Pharmaceuticals Company Information
  75. 8.13.2 Gan & Lee Pharmaceuticals Business Overview
  76. 8.13.3 Gan & Lee Pharmaceuticals GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Gan & Lee Pharmaceuticals GLP-1 Injection Product Portfolio
  78. 8.13.5 Gan & Lee Pharmaceuticals Recent Developments
  79. 8.14 Borui Pharmaceuticals
  80. 8.14.1 Borui Pharmaceuticals Company Information
  81. 8.14.2 Borui Pharmaceuticals Business Overview
  82. 8.14.3 Borui Pharmaceuticals GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Borui Pharmaceuticals GLP-1 Injection Product Portfolio
  84. 8.14.5 Borui Pharmaceuticals Recent Developments
  85. 8.15 Imeik
  86. 8.15.1 Imeik Company Information
  87. 8.15.2 Imeik Business Overview
  88. 8.15.3 Imeik GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Imeik GLP-1 Injection Product Portfolio
  90. 8.15.5 Imeik Recent Developments
  91. 8.16 Novo Nordisk
  92. 8.16.1 Novo Nordisk Company Information
  93. 8.16.2 Novo Nordisk Business Overview
  94. 8.16.3 Novo Nordisk GLP-1 Injection Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Novo Nordisk GLP-1 Injection Product Portfolio
  96. 8.16.5 Novo Nordisk Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Injection Value Chain Analysis
  2. 9.1.1 GLP-1 Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Injection Sales Mode & Process
  6. 9.2 GLP-1 Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Injection Distributors
  9. 9.2.3 GLP-1 Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst